Protein Summary
Core component of the 3M and Cul7-RING(FBXW8) complexes, which mediates the ubiquitination of target proteins. Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695). Interaction with CUL9 is required to inhibit CUL9 activity and ubiquitination of BIRC5 (PubMed:24793696). Core component of a Cul7-RING ubiquitin-protein ligase with FBXW8, which mediates ubiquitination and consequent degradation of target proteins such as GORASP1, IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026). Ubiquitination of GORASP1 regulates Golgi morphogenesis and dendrite patterning in brain (PubMed:21572988). Mediates ubiquitination and degradation of IRS1 in a mTOR-dependent manner: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2) (PubMed:18498745) ...more
- ENST00000265348
- ENSP00000265348
- ENSG00000044090
- ENST00000535468
- ENSP00000438788
- KIAA0076
- 3M1
- CUL-7
- KIAA0076
- dJ20C7.5
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 0.92 | ||
protein domain | 0.92 | ||
transcription factor binding site profile | 0.79 | ||
phenotype | 0.63 | ||
cell line | 0.62 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 58.46 (req: < 5)
Gene RIFs: 32 (req: <= 3)
Antibodies: 171 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 58.46 (req: >= 5)
Gene RIFs: 32 (req: > 3)
Antibodies: 171 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 15
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0
Protein Sequence and Structure
Residue Counts
Protein Sequence
ProtVista Viewer
Expression Data (0 Tissues)
Related Tools

TIGA scores and ranks GWAS discovered associations according to the quantity and quality of the evidence supporting the association.

GENEVA (GENe Expression Variance Analysis) allows you to identify RNA-sequencing datasets from the Gene Expression Omnibus (GEO) that contain conditions modulating a gene or a gene signature.

GlyGen is a data integration and dissemination project for carbohydrate and glycoconjugate related data.

ARCHS4 provides access to gene-function predictions based on RNA-seq co-expression, and gene expression levels across cell and tissues.
Approved Drugs (0)
Active Ligands (0)
Protein-Protein Interactions (327)
GLMN
Novelty: 0.01940401
p_int: 0.999999796
p_ni: 2.04e-7
Score: 0.984
Data Source: BioPlex,STRINGDB
SKP1
Family: Enzyme
Novelty: 0.00149739
p_int: 0.999999361
p_ni: 6.4e-7
Score: 0.981
Data Source: BioPlex,STRINGDB
MAPK14
Family: Kinase
Novelty: 0.00045138
p_int: 0.999998204
p_ni: 0.000001796
Score: 0.776
Data Source: BioPlex,STRINGDB
TP53
Family: TF
Novelty: 0.00001907
p_int: 0.999991499
p_ni: 0.000008501
Score: 0.661
Data Source: BioPlex,STRINGDB
KLHL2
Novelty: 0.07279226
p_int: 0.999955786
p_ni: 0.000044214
Score: 0.929
Data Source: BioPlex,STRINGDB
DGKG
Family: Enzyme
Novelty: 0.03666646
p_int: 0.999904325
p_ni: 0.000095675
Data Source: BioPlex
Nearest Tclin Targets
Pathways (12)
Reactome (10)
KEGG (1)
UniProt (1)
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Adaptive Immune System | ||||
Reactome | Antigen processing: Ubiquitination & Proteasome degradation | ||||
Reactome | Class I MHC mediated antigen processing & presentation | ||||
Reactome | IRE1alpha activates chaperones | ||||
Reactome | Immune System | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Adaptive Immune System | ||||
Antigen processing: Ubiquitination & Proteasome degradation | ||||
Class I MHC mediated antigen processing & presentation | ||||
IRE1alpha activates chaperones | ||||
Immune System | ||||
Viral Interactions (0)
Gene Ontology Terms (23)
Functions (1)
Components (8)
Processes (14)
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Electronic Annotation (IEA) | InterPro | |||
Disease Associations ()
GWAS Traits (8)
Items per page:
1 – 5 of 8
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
apolipoprotein A 1 measurement | 2 | 3 | 3 | 92.7 | |||||
apolipoprotein B measurement | 2 | 3 | 3 | 86.8 | |||||
high density lipoprotein cholesterol measurement | 2 | 2 | 3 | 79.6 | |||||
bilirubin measurement | 1 | 1 | 1 | 67.3 | |||||
homocysteine measurement | 1 | 1 | 1 | 47.7 | |||||
Items per page:
1 – 5 of 8
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
apolipoprotein A 1 measurement | 3 | 92.7 | |||||
apolipoprotein B measurement | 3 | 86.8 | |||||
high density lipoprotein cholesterol measurement | 3 | 79.6 | |||||
bilirubin measurement | 1 | 67.3 | |||||
homocysteine measurement | 1 | 47.7 | |||||
Find similar targets by:
IDG Resources
Orthologs (6)
1 – 5 of 6
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | cullin 7 | VGNC:2679 | 472011 | |||||
Macaque | cullin 7 | 699545 | ||||||
Mouse | MGI:1913765 | 66515 | ||||||
Rat | RGD:1587048 | 680835 | ||||||
Horse | cullin 7 | VGNC:16972 | 100067262 | |||||
Publication Statistics
PubMed Score 58.46
PubMed score by year
PubTator Score 34.66
PubTator score by year
Related Publications
Text Mined References (50)
GeneRif Annotations (32)
Items per page:
0 of 0
PMID | Year | Title |
---|